Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Lymphoma, Large B-Cell, Diffuse
×
fludarabine phosphate
×
Clear all
Filters
3
NCT06500273
2026-03-18
ALPHA3
Allogene Therapeutics
Phase 2
Recruiting
250 enrolled